← SynDRA
thiostrepton
SynDRA canonical compound SYN0042191 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | FOXM1 |
|---|
| Mechanism of action | Protein synthesis inhibitor |
|---|
| Indication | mastitis |
|---|
| Disease area | obstetrics/gynecology |
|---|
All known targets
Mechanisms of action (all sources)
- FOXM1 INHIBITOR
- Protein synthesis inhibitor
- foxm1 inhibitor, protein synthesis inhibitor
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
Cross-references
Synonyms
- Thiostrepton from Streptomyces azureus
- Bryamycin
- Thiactin
- Alaninamide,
- NSC81722
- NSC170365
- NSC-81722
- NSC-170365
- CHEMBL1981887
- CHEBI:94340
- MolPort-003-939-599
- NCGC00485235-01
- Thiostrepton from Streptomyces azureus, >
- SR-05000001899
- NCGC00016576-01
- CAS-1393-48-2
- Prestwick2_000522
- SCHEMBL25847
- BSPBio_002468
- SPECTRUM1505111
- CHEMBL410968
- HMS1569J05
- HMS2093I06
- Pharmakon1600-01505111
- Tox21_110504
- NSC759821
- AKOS026750174
- CCG-213336
- NSC-759821
- NCGC00096010-01
- NCGC00096010-02
- SBI-0206784.P001
- AB01563039_01
- SR-05000001899-1
- SR-05000001899-3
- SR-05000001899-4
- Gargon
Look up thiostrepton in the interactive SynDRA portal →